Mass Spectrometry Imaging in Cancer Research: Future Perspectives

Area of Science:

• Biomedical Sciences
• Analytical Chemistry
• Pathology

Background:

• Mass spectrometry imaging (MSI) has seen significant advancements in instrumentation, target molecules, and applications over the past decade.
• MSI has demonstrated a substantial impact on cancer research, aiding in the understanding of disease progression, diagnosis, and prognosis.
• Current research increasingly utilizes formalin-fixed paraffin-embedded (FFPE) cancer tissues, including tissue blocks, biopsy specimens, and tumor microarrays.

Purpose of the Study:

• To provide a perspective on current and future methodological developments in mass spectrometry imaging.
• To explore how these advancements can open new opportunities for cancer research.
• To highlight the utility of MSI in drug formulation development for determining drug and metabolite distributions.

Main Methods:

• Review of recent innovations in mass spectrometry imaging instrumentation.
• Analysis of expanded target molecule capabilities in MSI.
• Examination of diverse application areas, with a focus on cancer research and drug development.

Main Results:

• MSI has become a powerful tool in cancer research, uncovering critical biomolecular changes.
• The integration of FFPE tissues has broadened the accessibility and application of MSI.
• MSI serves as a cost-effective method for analyzing drug and metabolite distributions in formulation development.

Conclusions:

• Continued methodological advancements in MSI are expected to drive significant progress in cancer research.
• The expanding applications of MSI will further enhance our understanding of cancer biology and treatment.
• MSI is poised to play an increasingly vital role in both fundamental cancer research and pharmaceutical development.